The report "Intraocular Lens Market byType (Monofocal, Premium, Phakic), Material (Hydrophobic, Hydrophilic, Silicone) Application (Cataract, Presbyopia, Corneal Disorder), End User, Unmet Need, Buying Criteria, Reimbursement - Global Forecast to 2029", to reach USD 6.0 billion by 2029 from 4.2 billion in 2023, at a CAGR of 6.3% during 2023-2029
Browse 222 market data Tables and 50 Figures spread through 248 Pages and in-depth TOC on "Intraocular Lens Market byType (Monofocal, Premium, Phakic), Material (Hydrophobic, Hydrophilic, Silicone) Application (Cataract, Presbyopia, Corneal Disorder), End User, Unmet Need, Buying Criteria, Reimbursement - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/intraocular-lens-market-263730551.html
The major driving factors for the growth of intraocular lens market include a growing global aging population, rising prevalence of cataracts, improving awareness regarding minimally invasive operations, and advancements in IOL technology. The intraocular lens market will be increasing in the emerging economies such as India and China due to increase in the population of cataract patients and hence it offers a significant growth opportunity for players in the intraocular lens market.
Premium IOLs is accounted for the fastest growing segment of the global intraocular lens market
Types of Intraocular lens market further segmented into Monofocal IOLs, Premium IOLs, Phakic IOLs, and others. Premium IOLs accounted for the fastest growing segment in the Intraocular lens market. IOLs with functionalities beyond simple vision correction are becoming increasingly popular among patients. They are looking for lenses that can improve near and intermediate vision, treat astigmatism, and manage presbyopia. Exquisite IOLs that meet these requirements and produce better visual results include multifocal, toric, and extended depth of focus (EDOF) lenses. Premium IOLs contribute to this by offering faster visual recovery, better vision quality, and improved quality of life. This emphasis on patient satisfaction further strengthens the demand for premium IOLs.
Aspheric Monofocal IOLs segment is accounted for the highest share of the mono-focal intraocular lens market
IOLs come in several types and aspheric monofocal IOLs holds a significant share in the intraocular lens market. Because of their non-spherical design, aspheric IOLs decrease the effect of spherical aberration, a common optical flaw that can result in haze and blurred vision. When compared to conventional spherical lenses, certain aspheric mono-focal IOLs provide a greater depth of focus. Patients may benefit from improved eyesight at intermediate distances, which will improve their capacity to conduct everyday tasks.
Hospitals accounted for highest share in the end user segment of the intraocular lens market
In End user segment, intraocular lens market is segmented into Hospitals, Ophthalmology Clinics, Eye Research Institutes, and Others. Hospital segments hold the highest market share in intraocular lens market. Factors such as large number of cataract surgeries performed, high adoption of novel technology in eye surgeries related to intraocular lenses, and comprehensive patient care, including pre-operative consultations, surgery, and post-operative follow-up helps the highest market share of the segment.
Asia Pacific is expected to grow at a significant CAGR during the forecast period
The population of Asia Pacific is the largest in the world, and a considerable proportion of that population is in the age range where cataracts are most likely to occur. There is a significant patient population for cataract surgery and IOL implantation due to the high frequency of cataracts. Families and individuals now have more discretionary income thanks to the Asia-Pacific area. Because of their increased purchasing power, more people are now able to purchase high-quality IOL alternatives and cataract surgery.
Key players in the Intraocular Lens market
The prominent players in the intraocular lens market are Alcon Inc. (US), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec AG (Germany), Hoya Corporation (Japan), Bausch & Lomb (US), STAAR Surgical (US), Santen Pharmaceutical Co., Ltd. (Japan), NIDEK Co., Ltd. (Japan), LENSTEC, Inc. (US), Rayner Group (England), Beaver-Visitec International (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]